{"status": "OK", "response": {"docs": [{"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": null, "headline": {"main": "Abortion in America and Europe", "kicker": "Ross Douthat"}, "abstract": "A response to critics on the lessons of Europe\u2019s abortion laws.", "print_page": null, "word_count": "1357", "_id": "5203da3479881007d590236c", "snippet": "A response to critics on the lessons of Europe\u2019s abortion laws.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://douthat.blogs.nytimes.com/2013/08/08/abortion-in-america-and-europe/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Davis, Wendy", "name": "persons", "rank": "1"}, {"value": "Ryan, Paul D Jr", "name": "persons", "rank": "2"}, {"value": "Europe", "name": "glocations", "rank": "1"}, {"value": "France", "name": "glocations", "rank": "2"}, {"value": "Germany", "name": "glocations", "rank": "3"}, {"value": "Ireland", "name": "glocations", "rank": "4"}, {"value": "Italy", "name": "glocations", "rank": "5"}, {"value": "Spain", "name": "glocations", "rank": "6"}, {"value": "Sweden", "name": "glocations", "rank": "7"}, {"value": "Texas", "name": "glocations", "rank": "8"}, {"value": "Planned Parenthood Federation of America", "name": "organizations", "rank": "1"}, {"value": "Abortion", "name": "subject", "rank": "1"}, {"value": "Pregnancy and Childbirth", "name": "subject", "rank": "2"}, {"value": "Women and Girls", "name": "subject", "rank": "3"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Ross", "lastname": "DOUTHAT"}], "original": "By ROSS DOUTHAT"}, "document_type": "blogpost", "pub_date": "2013-08-08T13:46:30Z", "section_name": "Opinion"}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": null, "headline": {"main": "Happy Birth Data! A New App Tracks Fertility", "kicker": "Bits"}, "abstract": "Max Levchin, a well-known tech entrepreneur, is taking data science to human conception and fertility with his new company, Glow.", "print_page": null, "word_count": "556", "_id": "5203de7b79881007d5902379", "snippet": "Max Levchin, a well-known tech entrepreneur, is taking data science to human conception and fertility with his new company, Glow.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://bits.blogs.nytimes.com/2013/08/08/happy-birth-data-a-new-app-tracks-fertility/", "multimedia": [{"subtype": "wide", "url": "images/2013/08/08/technology/08bits-glow1/08bits-glow1-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2013/08/08/technology/08bits-glow1/08bits-glow1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2013/08/08/technology/08bits-glow1/08bits-glow1-articleLarge.jpg", "height": 1065, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2013/08/08/technology/08bits-glow1/08bits-glow1-articleLarge.jpg", "xlargeheight": "1065"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2013/08/08/technology/08bits-glow1/08bits-glow1-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/08/08/technology/08bits-glow1/08bits-glow1-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Levchin, Max", "name": "persons", "rank": "1"}, {"value": "Google Inc", "name": "organizations", "rank": "1"}, {"value": "PayPal", "name": "organizations", "rank": "2"}, {"value": "Health Insurance and Managed Care", "name": "subject", "rank": "1"}, {"value": "Mobile Applications", "name": "subject", "rank": "2"}, {"value": "Pregnancy and Childbirth", "name": "subject", "rank": "3"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Quentin", "lastname": "HARDY"}], "original": "By QUENTIN HARDY"}, "document_type": "blogpost", "pub_date": "2013-08-08T09:00:05Z", "section_name": "Technology"}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "OpEd", "lead_paragraph": "The Food and Drug Administration finally required that mefloquine hydrochloride, brand name Lariam, carry a \u201cblack box\u201d for side effects. But it\u2019s too little, too late.", "headline": {"main": "Crazy Pills", "kicker": "Op-Ed Contributor", "print_headline": "Crazy Pills", "content_kicker": "Op-Ed Contributor"}, "abstract": "Op-Ed article by author David Stuart MacLean describes suffering from severe adverse psychiatric side effects from taking anti-malarial drug mefloquine hydrochloride; notes that the Food and Drug Administration has finally acknowledged that neurological and psychiatric side effects of the drug are serious enough to warrant a warning label; laments that the FDA decision has come too late, as the side effects could be permanent.", "print_page": "23", "word_count": "834", "_id": "5202ee4379881007d5902131", "snippet": "The Food and Drug Administration finally required that mefloquine hydrochloride, brand name Lariam, carry a \u201cblack box\u201d for side effects. But it\u2019s too little, too late.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2013/08/08/opinion/crazy-pills.html", "multimedia": [{"subtype": "wide", "url": "images/2013/08/08/opinion/0808OPEDsampson/0808OPEDsampson-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2013/08/08/opinion/0808OPEDsampson/0808OPEDsampson-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2013/08/08/opinion/0808OPEDsampson/0808OPEDsampson-articleLarge.jpg", "height": 835, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2013/08/08/opinion/0808OPEDsampson/0808OPEDsampson-articleLarge.jpg", "xlargeheight": "835"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2013/08/08/opinion/0808OPEDsampson/0808OPEDsampson-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/08/08/opinion/0808OPEDsampson/0808OPEDsampson-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Malaria", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "2", "name": "organizations"}, {"value": "Labeling and Labels", "is_major": "N", "rank": "4", "name": "subject"}], "byline": {"contributor": "", "person": [{"firstname": "David", "middlename": "Stuart", "lastname": "MacLEAN", "rank": 1, "role": "reported", "organization": ""}], "original": "By DAVID STUART MacLEAN"}, "document_type": "article", "pub_date": "2013-08-08T00:00:00Z", "section_name": "Opinion"}], "meta": {"hits": 13, "offset": 10, "time": 9}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}